This study investigates the effects of follicle stimulating hormone (FSH) or epidermal growth factor (EGF) on the development of mouse oocytes matured in vitro. The data show that addition of FSH or EGF does not significantly increase the proportion of oocytes maturing to metaphase II but does increase the ability of these oocytes to cleave to the 2-cell stage after fertilization. After transfer of 2-cell embryos to pseudopregnant recipients, 64-78% of the embryos implanted, which was significantly reduced compared to embryos from in-vivo matured controls (89%). Fewer fetuses at day 14 of gestation were produced from embryos derived from oocytes matured in basal conditions (26%), or in the presence of EGF (32%), compared to oocytes matured in vivo (64%) or in the presence of FSH (58%). Examination of polar bodies and pronuclei of oocytes matured in vitro suggests that an increase in the rate of triploidy may be partly responsible for the increased fetal loss after maturation in the absence of FSH. This study shows that the fertilization rate after in-vitro maturation can be improved by FSH and EGF and that subsequent embryonic development is improved specifically by FSH.
Introduction
In the pre-ovulatory follicle, the fully grown immature oocyte is surrounded by several layers of granulosa cells, the cumulus oophorus. The oocyte and cumulus cells are coupled by gap junctions and form a functional syncytium known as the cumulus-oocyte complex (COC) (Gilula et al., 1978) . The pre-ovulatory surge of gonadotrophins stimulates two events: oocyte maturation and cumulus expansion. Oocyte maturation involves progression from prophase of the first meiotic division to metaphase of the second meiotic division (MII). The first indication of the resumption of meiosis is germinal vesicle breakdown (GVBD), which occurs about 2 h after the stimulus. The oocyte then proceeds through the first meiotic division before arresting at MII~10 h later. In addition to these cell cycle events, modifications also occur in the oocyte cytoplasm to ensure that normal fertilization can take place. These include 690 © European Society for Human Reproduction and Embryology increased concentrations of glutathione (Perreault et al., 1988) and an increased capacity for release of intracellular calcium (Fujiwara et al., 1993; Carroll et al., 1996) .
The second luteinizing hormone (LH)-induced event is cumulus expansion, which involves the secretion by the cumulus cells of a hyaluronic acid-rich proteoglycan matrix (Salustri et al., 1989) . The cumulus cells disperse within the matrix which, together with a mature MII arrested oocyte, is ovulated approximately 12 h after the LH surge. In COC cultured in vitro, cumulus expansion can be stimulated by follicle stimulating hormone (FSH), epidermal growth factor (EGF) or agents that increase cAMP in the cumulus cells (Dekel and Kracier, 1978; Eppig, 1979a,b; Hillensjo and Channing, 1980; Downs, 1989; Salustri et al., 1989) . Serum (Eppig, 1979b) and substrates for hyaluronic acid synthesis (Chen et al., 1990) are also essential for the formation and stability of the hyaluronic acid extracellular matrix in vitro.
The physiological trigger for meiotic resumption is the surge of LH, but it can also occur spontaneously on release from antral follicles and culture in vitro (Pincus and Enzman, 1935; Edwards, 1965) . Meiotic arrest can be maintained in vitro by elevating the concentrations of oocyte intracellular cAMP (Cho et al., 1974; Magnusson and Hillensjo, 1977; Schultz et al., 1983) , suggesting a role for this second messenger in the regulation of meiosis. This inhibitory effect of cAMP on oocyte maturation can be overcome by FSH and EGF in a manner that is dependent upon the presence of cumulus cells (Downs et al., 1988) . A number of studies in a variety of species have shown that addition of FSH and/or EGF to the maturation medium improves the rate of oocyte maturation (mouse, Eppig and Schroeder, 1989; Jinno et al., 1990; pig, Ding and Foxcroft, 1994; cow, Lorenzo et al., 1994; human, Gomez et al., 1993) .
The ability of in-vitro matured oocytes to be fertilized and develop in vitro and in vivo has been shown for a number of species. Few controlled studies have been carried out but it is the general consensus that the developmental potential of invitro matured oocytes is compromised compared to their invivo matured counterparts. However, it has been clearly demonstrated that, in ideal conditions, in-vitro maturation has no effect on subsequent developmental potential of mouse oocytes (Schroeder and Eppig, 1984) . Other studies indicate that in-vitro matured oocytes are more sensitive to sub-optimal culture conditions than in-vivo matured oocytes (Jinno et al., 1989) and that culture medium can influence in-vitro and invivo development (Van de Sandt et al., 1990) . Supplementation of the maturation medium with EGF has been shown to improve embryonic development in vitro of in-vitro matured mouse and pig oocytes (Das et al., 1991; Ding and Foxcroft, 1994) . The aim of the present study was to compare directly the developmental potential of mouse oocytes matured in the presence of FSH and EGF. We find in-vitro matured oocytes have a poor rate of development to the blastocyst stage in vitro and that FSH or EGF afford no improvement. However after transfer at the 2-cell stage, embryos developed from oocytes matured in the presence of FSH, but not EGF, develop to late stage fetuses at rates similar to in-vivo matured controls.
Materials and methods
All manipulations of COC and mature oocytes were performed in medium maintained at 37°C. COC, oocytes and embryos were cultured in 5% CO 2 in air in humidified incubators at 37°C.
Collection of COC
Twenty-one day old B6CB (C57BL6/6JLacϫCBA/CaLac) F 1 hybrid mice were killed by cervical dislocation, 48-52 h after i.p. administration of 7.5 IU of pregnant mares' serum gonadotrophin (PMSG; Folligon: Intervet, Cambridge, UK). The ovaries were removed and transferred into medium M2 (Fulton and Whittingham, 1978) containing 5% fetal bovine serum (FBS; ICN Flow, High Wycombe, UK). COC were released from the large antral follicles by puncturing with a sterile 25 gauge needle. Only COC enclosed with intact cumulus layers were selected for in-vitro maturation.
In-vitro maturation COC were washed three times in Waymouth's MB 752/1 medium (Gibco-BRL, Irvine, UK) supplemented with 25 mmol/l sodium bicarbonate, 0.33 mmol/l pyruvate, 60 mg/l benzyl penicillin sodium BP and 50 mg/l streptomycin sulphate BP and 5% FBS. The effects of FSH and EGF on the development of in-vitro matured oocytes was carried out in two separate series of experiments. Groups of 20-40 COC were cultured in 50 µl drops of culture medium, basal conditions (control) or in the presence of 1 µg/ml FSH (oFSH; National Hormone and Pituitary Program of the University of Maryland Medical School, Bethesda, MD, USA) or 1 ng/ml EGF (Sigma Chemical Co., Poole, Dorset, UK) under oil for 15-16 h. Expanded cumulus cell masses were removed from the oocytes by adding 10 µl of a stock solution of hyaluronidase (150 IU/ml) (Sigma), to the maturation medium. The cumulus-free oocytes were removed and washed three times in M2 prior to IVF. Oocytes were scored for stages of meiotic maturation according to the presence (GV) or absence (GVBD) of the germinal vesicle, or the presence of the first polar body (PB1). Oocytes that had an extruded first polar body (PB1) were used for in-vitro fertilization (IVF).
Collection of in-vivo matured oocytes
Twenty-one day old B6CBF 1 hybrid mice were superovulated by i.p. injections of 7.5 IU PMSG, followed by 5 IU of human chorionic gonadotrophin (HCG, Chorulon; Intervet). The mice were killed by cervical dislocation 15-16 h post-HCG. The oviducts were removed and transferred to M2 containing 150 IU/ml hyaluronidase into which the cumulus masses were released to remove the cumulus cells. The cumulus-free mature oocytes were collected and washed three times in M2 prior to IVF.
In-vitro fertilization (IVF) and embryo transfer
The procedures used for IVF and embryo transfer have been previously described in detail by Glenister et al. (1987) . Briefly, in-vitro and invivo matured oocytes were inseminated with capacitated B6CBF 1 spermatozoa at a concentration of 1-2ϫ10 6 /ml in medium T6 (Quinn 691 et al., 1982) supplemented with 15 mg/ml BSA (fraction V, Sigma). After 4 h the oocytes were removed and washed three times in medium M16 (Whittingham, 1971 ) before being transferred to 10 µl M16 culture drops under paraffin oil. The number of oocytes cleaving to the 2-cell stage after 24 h was recorded. The 2-cell embryos were transferred to oviducts of B6CBF 1 recipients on day 1 of pseudopregnancy. The recipient females were autopsied on day 14 of gestation, when the number of implantation sites and fetuses were recorded. In a preliminary study to investigate developmental capacity in vitro, the 2-cell embryos were cultured for 4 days and the number developing to the blastocyst stage was recorded.
DNA staining of fertilized oocytes
Oocytes were fixed in 2% (v/v) glutaraldehyde in PBS containing 4 mg/ml polyvinyl alcohol (PVA; Sigma) for 5 min and washed three times in PBS ϩ PVA. To stain the DNA, oocytes were incubated for 10 min in PBS ϩ PVA containing 16 ng/ml Hoechst 33258. After staining, the oocytes were washed three times in PBS ϩ PVA, mounted onto microscope slides and visualized using epifluorescence microscopy.
Statistical analysis
Oocyte maturation and rates of IVF were analysed using two-way analysis of variance (ANOVA) after angular transformation. The embryo transfer data were pooled from three replicate experiments of both FSH and EGF studies and analysed using the χ 2 test. The rates of sperm penetration, pronuclear formation and second polar body extrusion were analysed using a χ 2 test.
Results

Effects of FSH and EGF on in-vitro maturation and embryonic development
In a preliminary study, the addition of FSH or EGF had no effect on the proportion of oocytes extruding the first polar body or on the number of oocytes that cleaved to the 2-cell stage after IVF. Subsequent development of 2-cell embryos to the blastocyst stage in vitro was Ͻ20% in all in-vitro matured groups compared to 78% in in-vivo matured controls. The low rates of in-vitro development after in-vitro maturation may be because the oocytes were developmentally abnormal or it may simply reflect a sensitivity to the culture conditions used in this study. To determine whether embryos that matured in these conditions had the capacity to develop to term a further study was carried out.
In the subsequent study, the addition of FSH or EGF had no effect on meiotic maturation but significantly improved the proportion of oocytes that formed 2-cell embryos after IVF (Table I) . The difference in the effects of FSH and EGF on fertilization between the preliminary trial and this one was most likely due to different sample sizes. To determine whether 2-cell embryos derived from in-vitro matured oocytes could develop in vivo, embryos were transferred to the oviducts of pseudopregnant recipients. A large proportion of embryos from in-vitro matured oocytes implanted (64-78%) (Table II) , although the proportion was significantly lower than for embryos from in-vivo matured controls (89%; P Ͻ 0.01). Of the in-vitro matured oocytes, FSH significantly improved the rate of implantation compared to oocytes matured in control conditions (78 versus 64%; P Ͻ 0.05; Table II). The ability of in-vitro matured oocytes to develop to fetuses after IVF and embryo transfer was dependent on the culture conditions. The rates of fetal development were similar in oocytes matured in vivo and in oocytes matured in the presence of FSH (Table II) . Maturation in the presence of FSH resulted in significantly more embryos developing to late stage fetuses (58%) than after maturation in the presence of EGF (32%) or in control conditions (26%; P Ͻ 0.001; Table II ).
Effect of FSH and EGF on pronuclear formation and polar body extrusion
To investigate a possible reason for the improved embryonic development after maturation in the presence of FSH, the ability of in-vitro matured oocytes to undergo normal fertilization was examined. At 8 h post-insemination, the proportion of oocytes that were penetrated by spermatozoa was significantly lower in all in-vitro matured oocytes compared to in-vivo matured oocytes (P Ͻ 0.01; Table III ). However, oocytes matured in the presence of FSH had a significantly increased rate of sperm penetration compared to those matured under control conditions or in the presence of EGF (P Ͻ 0.025; Table III ).
The proportion of oocytes that underwent normal fertilization, as signified by the presence of a second polar body and two pronuclei, was significantly reduced after in vitro maturation (P Ͻ 0.01; Table III ). The main reason for abnormal 692 fertilization was a significant increase in the formation of triploid embryos after fertilization. The frequency of triploidy after the fertilization of oocytes matured in the absence of FSH was significantly greater than after maturation in the presence of FSH (P Ͻ 0.05) or after maturation in vivo (P Ͻ 0.01). The frequency of triploidy after maturation in the presence of EGF was similar to that of oocytes matured in control conditions and significantly greater than after maturation in vivo (P Ͻ 0.01). Closer examination of the triploid embryos revealed that the majority did not extrude a second polar body (Table III) . This suggested that triploidy after invitro maturation was caused by failure to extrude the second polar body and not from polyspermic fertilization. It was also observed that a percentage of the triploid oocytes had a visible cleavage furrow, suggesting that cytokinesis (polar body extrusion) had been attempted, but was aborted.
Discussion
This study compares the effect of FSH and EGF on the development of in-vitro matured oocytes. We show that FSH and EGF can improve the rate of fertilization after in-vitro maturation. The ability of embryos derived from oocytes matured in control conditions to form fetuses after embryo transfer was significantly reduced compared to ovulated (4) oocytes. The use of FSH (but not EGF) during oocyte maturation significantly improved fetal development. We suggest that at least some of the post-implantation fetal loss is a result of an increased rate of triploidy after maturation in the absence of FSH. Furthermore, we find that culture conditions during in-vitro maturation can induce an in-vitro block to development that can be readily circumvented by transferring the embryos to the oviduct. The effects of FSH and EGF on the ability of embryos developed from in-vitro matured oocytes to cleave to the 2-cell stage may be mediated at a number of different concentrations. The outer vestments of the oocyte, the cumulus cells and the zona pellucida, are possible sites of action. The most obvious effect of both FSH and EGF is that they stimulate cumulus expansion. This may provide the spermatozoa with easier access to the zona pellucida, or may render the zona pellucida easier to penetrate by the fertilizing spermatozoon. The latter explanation is the more likely in this study, since the cumulus cells were removed prior to carrying out IVF. A further explanation may be that in the absence of FSH or EGF, the spermatozoon penetrates the zona pellucida and fuses with the oocyte but is unable to form a pronucleus in the cytoplasm of oocytes matured in control conditions. This possibility is supported by the finding that 61% of oocytes were penetrated by spermatozoa when examined using Hoechst (Table III ), yet only 46% of embryos developed from those oocytes cleaved to the 2-cell stage after fertilization (Table I) . Thus FSH and EGF appear to improve fertilization by two mechanisms: firstly by inhibiting zona hardening, perhaps by inducing cumulus expansion, and secondly, by increasing the ability of in-vitro matured oocytes to support male pronucleus formation.
Although FSH and EGF can improve fertilization rates, only FSH appears to improve the developmental capacity of invitro matured oocytes. This indicates that in the case of fertilization, FSH and EGF may be acting via a similar mechanism, while in the case of embryonic development, FSH has additional effects on the oocyte not afforded by EGF. The precise nature of these effects is not known. One major 693 difference is the signal transduction pathways stimulated by these two agents. The FSH receptor activates a G-protein coupled to adenylate cyclase leading to an increase in cAMP, while the EGF receptor is a tyrosine kinase. One difference in their actions reflects these differing signal transduction pathways. The rate of GVBD is delayed by FSH and not by EGF (Downs et al., 1988) , presumably due to a transient increase in cAMP concentrations in response to FSH. This delay may contribute to the improved development of invitro matured oocytes by allowing the synchronization of cytoplasmic and nuclear components of oocyte maturation (Eppig, 1996) . Further understanding of why in-vitro matured oocytes fail may provide some insight into how FSH acts to improve embryonic development.
One possible mechanism is suggested by the finding that maturation in the presence of FSH decreases the rate of triploidy after fertilization. Triploid embryos are capable of implanting but resorb soon afterwards (Kaufman, 1991; BosMikich and Whittingham, 1992 for review), which is when we find that most of the embryo loss occurs after maturation in the absence of FSH. The triploidy appears to arise from retention of the second polar body after fertilization. Although this categorization is based entirely on morphology and requires independent confirmation, it is consistent with a number of observations; firstly, the inability to detect a second polar body in the presence of three pronuclei; secondly, that many of the triploid embryos had apparently attempted to extrude a polar body as indicated by a cleavage furrow; and thirdly, the finding that in-vitro maturation inhibits the rate of fertilization runs counter to the possibility that triploidy results from polyspermic fertilization.
The inability to extrude the second polar body in a proportion of in-vitro matured oocytes may be due to cytoskeletal abnormalities. An actin-rich layer overlies the second meiotic spindle in the unfertilized oocyte, which is important for normal polar body extrusion (Maro et al., 1984) . Therefore, one possible reason for the increase in the number of triploid embryos may be that in-vitro maturation inhibits the formation of the layer of cortical actin. Further direct studies are required, but there is some experimental evidence to support this hypothesis. The presence of FSH during the maturation of hamster oocytes increases the amount of polymerized actin in the oocyte cortex. Furthermore, the presence of cortical actin leads to improved rates of polar body extrusion (Plancha and Albertini, 1994) . Other less direct evidence is that manipulations such as oocyte ageing and oocyte cryopreservation, which have been shown to disrupt the cytoskeleton, are also associated with abnormalities of polar body extrusion after fertilization or activation (Webb et al., 1986; Carroll et al., 1989; Bouquet et al., 1992) .
Despite finding that embryos derived from in-vitro matured oocytes were capable of implanting and forming fetuses at significant rates, development in vitro was found to be poor and restricted to the early cleavage divisions (2-to 4-cell stage). The culture conditions were clearly sufficient to support development of in-vivo matured oocytes since, after fertilization, 78% of these formed blastocysts (preliminary study). This suggests that the conditions during in-vitro maturation sensitized the embryos to the culture conditions used for embryo culture. This in-vitro developmental block of embryos from in-vitro matured oocytes is reminiscent of the so-called in-vitro 2-cell block which is apparent in the majority of mouse strains (Muggleton-Harris et al., 1982) . The development of in-vitro matured oocytes in culture has been shown to be affected by the culture medium used for maturation (van de Sandt et al., 1990) , and culture media have been formulated to improve the development of embryos from the blocking strains of mice. Some of these modifications appear to be beneficial to the in-vitro development of in-vitro matured oocytes (Jinno et al., 1989) . Clearly there is a potential for in-vitro matured mouse oocytes to be rendered sensitive to some (present study, Jinno et al., 1989 Jinno et al., , 1990 , but not all (Schroeder and Eppig, 1984) in-vitro culture systems. Nevertheless, the ultimate test of developmental competence is the ability of embryos to develop in vivo. Our studies show that in-vitro development cannot reliably be used as an indicator of cytoplasmic maturation or of full-term developmental potential.
